Walgreens Daily Repair Psoriasis Moisturizer

Description

WALGREENS DAILY REPAIR PSORIASIS MOISTURIZER is presented in a dosage form of a topical moisturizer, contained in a 4 fluid ounce (118 mL) bottle. The product is identified by the National Drug Code (NDC) 0363-0920-04.

Uses and Indications

This drug is indicated for the relief and prevention of recurrence of skin itching, irritation, redness, flaking, and scaling associated with psoriasis. It is designed to provide symptomatic relief for patients experiencing these dermatological conditions.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to the affected areas one to four times daily, or as directed by a healthcare professional. It is important to follow the prescribed frequency to ensure optimal therapeutic effects.

Contraindications

There are no specific contraindications associated with this product. However, it is advised to discontinue use and consult a healthcare professional if the condition worsens or does not improve after regular use as directed. Additionally, avoid contact with eyes; in the event of contact, rinse eyes thoroughly with water.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if the condition worsens or fails to improve after consistent application of the product as directed.

In cases of ingestion, it is crucial to obtain emergency medical help or reach out to a Poison Control Center immediately.

Side Effects

For external use only. Patients are advised to stop use and consult a doctor if their condition worsens or does not improve after regular use of this product as directed. Additionally, it is recommended that patients ask a doctor before use if they have psoriasis that covers a large area of the body.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Daily Repair Psoriasis Moisturizer (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may use Walgreens Daily Repair Psoriasis Moisturizer; however, the drug insert does not provide specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for this population.

Healthcare providers should exercise caution when recommending this product to geriatric patients, as the absence of targeted data necessitates careful monitoring for any potential adverse effects or interactions. It is advisable to consider the individual health status and needs of elderly patients when incorporating this moisturizer into their skincare regimen.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled accordingly.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific contraindications. Further clinical judgment should be applied based on the individual circumstances of the lactating mother and her breastfed infant.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure their safety while on treatment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, it is crucial to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized to ensure patient safety and mitigate potential complications associated with overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens or does not improve after regular use of the product as directed. It is important for healthcare providers to emphasize the necessity of following the usage instructions carefully.

When using this product, patients should be cautioned to avoid contact with their eyes. In the event of accidental eye contact, they should rinse their eyes thoroughly with water.

Additionally, healthcare providers should recommend that patients consult a doctor before using this product if they have psoriasis that covers a large area of the body. This precaution is essential to ensure safe and effective use of the product.

Storage and Handling

The product is available in various package configurations, identified by their respective NDC numbers. Specific storage and handling instructions have not been provided. Therefore, it is recommended that the product be stored in a manner consistent with standard pharmaceutical practices to ensure its integrity and efficacy.

Healthcare professionals should ensure that the product is kept in a suitable environment, taking into account general guidelines for pharmaceutical storage.

Additional Clinical Information

Patients should be aware that the medication may stain certain fabrics. Clinicians are advised to inform patients about this potential issue to prevent any unintended damage to clothing or other materials.

Drug Information (PDF)

This file contains official product information for Walgreens Daily Repair Psoriasis Moisturizer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)